Russell Investments Group Ltd. lessened its position in shares of Albemarle Co. (NYSE:ALB – Free Report) by 28.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 92,223 shares of the specialty chemicals company’s stock after selling 36,949 shares during the quarter. Russell Investments Group Ltd. owned about 0.08% of Albemarle worth $20,513,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of ALB. CENTRAL TRUST Co raised its stake in Albemarle by 3.4% during the third quarter. CENTRAL TRUST Co now owns 1,149 shares of the specialty chemicals company’s stock worth $304,000 after purchasing an additional 38 shares during the period. Covestor Ltd raised its stake in shares of Albemarle by 51.2% in the 1st quarter. Covestor Ltd now owns 130 shares of the specialty chemicals company’s stock valued at $29,000 after acquiring an additional 44 shares during the period. McIlrath & Eck LLC raised its stake in shares of Albemarle by 39.0% in the 4th quarter. McIlrath & Eck LLC now owns 164 shares of the specialty chemicals company’s stock valued at $36,000 after acquiring an additional 46 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of Albemarle by 1.0% in the third quarter. Thrivent Financial for Lutherans now owns 5,212 shares of the specialty chemicals company’s stock valued at $1,378,000 after purchasing an additional 50 shares in the last quarter. Finally, Cullen Frost Bankers Inc. grew its holdings in shares of Albemarle by 0.8% in the second quarter. Cullen Frost Bankers Inc. now owns 6,651 shares of the specialty chemicals company’s stock valued at $1,484,000 after purchasing an additional 51 shares in the last quarter. Institutional investors own 84.71% of the company’s stock.
Insider Activity at Albemarle
In other Albemarle news, EVP Kristin M. Coleman acquired 1,373 shares of the stock in a transaction that occurred on Tuesday, November 7th. The shares were purchased at an average cost of $121.86 per share, with a total value of $167,313.78. Following the purchase, the executive vice president now owns 2,746 shares in the company, valued at $334,627.56. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.38% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Albemarle Stock Performance
NYSE:ALB opened at $130.36 on Tuesday. The stock has a market cap of $15.30 billion, a PE ratio of 4.62, a price-to-earnings-growth ratio of 0.52 and a beta of 1.67. Albemarle Co. has a fifty-two week low of $112.00 and a fifty-two week high of $293.01. The firm’s fifty day simple moving average is $149.59 and its 200-day simple moving average is $188.04. The company has a quick ratio of 0.94, a current ratio of 1.81 and a debt-to-equity ratio of 0.34.
Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported $2.74 EPS for the quarter, missing analysts’ consensus estimates of $3.70 by ($0.96). The business had revenue of $2.31 billion during the quarter, compared to analyst estimates of $2.52 billion. Albemarle had a net margin of 33.63% and a return on equity of 36.09%. Albemarle’s revenue was up 10.5% on a year-over-year basis. During the same period in the previous year, the company posted $7.50 earnings per share. Analysts expect that Albemarle Co. will post 21.82 earnings per share for the current fiscal year.
Albemarle Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.60 dividend on an annualized basis and a yield of 1.23%. Albemarle’s payout ratio is 5.67%.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.
- Five stocks we like better than Albemarle
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Safeguard your portfolio with these three bargain stocks
- What Are Dividend Contenders? Investing in Dividend Contenders
- Membership clubs gain leverage for the consumer rebound
- Investing in Agriculture 101: How to Invest in Agriculture
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.